3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
20
Lymphoma
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Smoldering Multiple Myeloma
1
Sarcoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Disease
1
Carcinoma
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Dexamethasone
21
Calcium Dobesilate
10
Melphalan
9
Bortezomib
8
Cyclophosphamide
7
Lenalidomide
6
pomalidomide
4
venetoclax
3
miridesap
3
daratumumab
3
ixazomib
2
belantamab mafodotin
2
Thalidomide
2
Doxycycline
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
selinexor
1
pegfilgrastim
1
isatuximab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carfilzomib
1
birtamimab
1
auricularum
1
Vinorelbine
1
Technetium Tc 99m Pyrophosphate
1
Technetium
1
Tacrolimus
1
Surveys and Questionnaires
1
Pharmaceutical Preparations
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Amyloidosis
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT02716103
2021-09-10
MRD
Boston Medical Center
Completed
45 enrolled